Research › Fact Sheets › MDT

MEDTRONIC PLC

LISTEDNYSE

SYMBOLMDT

SIC3845

STATE OF INC.–

FISCAL YEAR ENDSApril 24

CIK1613103

ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · LARGE ACCELERATED FILER · 10 FISCAL YEARS OF SEC XBRL DATA, 2017–2026

Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.

CAPITALIZATION 4/24/26

($ millions)	Amount	%
Total debt	27,961	36.1
Stockholders' equity	49,463	63.9
Total capitalization	77,424	100.0

1,279,137,890 shares outstanding at 28 August 2026 (cover page of the 10-Q filed 3 September 2026).

LONG-TERM DEBT 4/24/26

($ millions)	Amount
Long-term debt, noncurrent	26,173
Current maturities	1,788

CAPITAL STOCK 4/24/26

Common shares authorized	2,600,000,000
Common shares issued	1,280,177,293
Par or stated value per share ($)	0.0001
Outstanding at 8/28/26	1,279,137,890

DIVIDENDS DECLARED/PAID

Fiscal year	Per share $	Payout %
2026	2.84	76.1
2025	2.80	77.6
2024	2.76	100.0
2023	2.72	96.5
2022	2.52	67.6

HISTORY AND BUSINESS

HISTORY: State of incorporation not stated in SEC records. Formerly known as Medtronic Ltd (to 15 January 2015); Medtronic Holdings Ltd (to 21 November 2014).

BUSINESS: Classified by the SEC under Standard Industrial Classification 3845, Electromedical & Electrotherapeutic Apparatus. Large accelerated filer. Principal executive office: Building Two Parkmore Business Park West, Galway, H91 4K49. Fiscal year ends April 24. For a description of the business, see Item 1 of the latest 10-K.

CONSOLIDATED INCOME ACCOUNT, YEARS ENDED

($ millions)	4/24/26	4/25/25	4/26/24
Revenues	36,364	33,537	32,364
Cost of revenues	12,721	11,632	11,216
Research and development	2,873	2,732	2,735
Selling, general and administrative	11,784	10,849	10,736
Depreciation and amortization	2,958	2,861	2,647
Operating income	6,467	5,955	5,144
Interest expense	715	729	719
Income before income taxes	6,136	5,628	4,837
Income taxes	1,299	936	1,133
Net income	4,801	4,662	3,676
Earned per share, diluted ($)	3.73	3.61	2.76
Dividends per share ($)	2.84	2.80	2.76

CONSOLIDATED BALANCE SHEET

($ millions)	4/24/26	4/25/25
Cash and equivalents	1,949	2,218
Receivables, net	6,643	6,515
Inventories	5,951	5,476
Total current assets	24,787	23,814
Property, plant and equipment, net	7,417	6,837
Goodwill	42,587	41,737
Total assets	93,028	91,680
Total current liabilities	11,658	12,879
Long-term debt	26,173	25,642
Total liabilities	42,956	43,424
Stockholders' equity	49,463	48,024
Total liabilities and equity	93,028	91,680

TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)

Fiscal year ended	Revenues	Oper. income	Net income	Net margin %	EPS diluted $	Div. per share $	Oper. cash flow	Capital expend.	Free cash flow	Total assets	Total liabilities	Total debt	Stockholders' equity	ROE %	Debt / equity
4/24/26	36,364	6,467	4,801	13.2	3.73	2.84	7,330	1,904	5,426	93,028	42,956	27,961	49,463	9.7	0.57
4/25/25	33,537	5,955	4,662	13.9	3.61	2.80	7,044	1,859	5,185	91,680	43,424	28,516	48,024	9.7	0.59
4/26/24	32,364	5,144	3,676	11.4	2.76	2.76	6,787	1,587	5,200	89,981	39,561	26,097	50,214	7.3	0.52
4/28/23	31,227	5,485	3,758	12.0	2.82	2.72	6,039	1,459	4,580	90,948	39,283	24,364	51,483	7.3	0.47
4/29/22	31,686	5,752	5,039	15.9	3.73	2.52	7,346	1,368	5,978	90,981	38,260	24,114	52,551	9.6	0.46
4/30/21	30,117	4,484	3,606	12.0	2.66	2.32	6,240	1,355	4,885	93,083	41,481	26,389	51,428	7.0	0.51
4/24/20	28,913	4,791	4,789	16.6	3.54	2.16	7,234	1,213	6,021	90,689	39,817	24,916	50,737	9.4	0.49
4/26/19	30,557	6,268	4,631	15.2	3.41	2.00	7,007	1,134	5,873	89,694	39,482	25,390	50,091	9.2	0.51
4/27/18	29,953	6,640	3,104	10.4	2.27	1.84	4,684	1,068	3,616	91,393	40,571	25,750	50,720	6.1	0.51
4/28/17	29,710	5,383	4,028	13.6	2.89	1.72	6,880	1,254	5,626	99,857	49,527	33,368	50,208	8.0	0.66

Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.

REGISTRANT:

Medtronic plc
CIK 1613103 · EIN 00-0000000

PRINCIPAL OFFICE:

Building Two Parkmore Business Park West, Galway, H91 4K49
Tel.: 01135314381700

INCORPORATED:

–

INDUSTRY (SEC SIC CODE):

3845 · Electromedical & Electrotherapeutic Apparatus

FILER STATUS:

Large accelerated filer

LATEST ANNUAL REPORT:

10-K for period ended 4/24/26, filed 18 June 2026

FORMER NAMES:

Medtronic Ltd; Medtronic Holdings Ltd

RECENT FILINGS (ANNUAL REPORT REFERENCES BELOW):

9/17/26	8-K	period 9/17/26
9/3/26	10-Q	period 7/31/26
9/1/26	8-K	period 9/1/26
8/17/26	DEF 14A	period 10/15/26
6/18/26	10-K	period 4/24/26
6/3/26	8-K	period 6/3/26
5/18/26	8-K	period 5/18/26
4/27/26	8-K	period 4/24/26

Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2026 (filed 6/18/26) · 10-K FY2025 (filed 6/20/25) · 10-K FY2024 (filed 6/20/24) · 10-K FY2023 (filed 6/22/23) · 10-K FY2022 (filed 6/23/22) · 10-K FY2021 (filed 6/25/21) · 10-K FY2020 (filed 6/19/20) · 10-K FY2019 (filed 6/21/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.